| RS2524347160 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS2524347327 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524348349 |
GNAT2
|
Health Risk |
Likely pathogenic |
— |
| RS2524349168 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524349632 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2524351874 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2524353140 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2524353808 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2524356477 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2524357635 |
MYSM1
|
Health Risk |
Pathogenic |
— |
| RS2524357772 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2524360107 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2524360459 |
SLC35A3
|
Health Risk |
Pathogenic |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |
| RS2524361370 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2524364976 |
DMD
|
Health Risk |
Likely pathogenic |
— |
| RS2524365256 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524366542 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2524367671 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524368407 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524369262 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2524370040 |
DMD
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2524372801 |
CLDN19
|
Health Risk |
Pathogenic |
Renal hypomagnesemia 5 with ocular involvement, Renal hypomagnesemia 5 with ocular involvement |
| RS2524373926 |
DPYD
|
Health Risk |
Likely pathogenic |
DPYD-related disorder, Dihydropyrimidine dehydrogenase deficiency |
| RS2524374326 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS2524375503 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524375517 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524375533 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524375738 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524375862 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524375879 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524375969 |
CLCNKB
|
Health Risk |
Pathogenic |
— |
| RS2524377118 |
AMPD2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9 |
| RS2524377730 |
VPS13D
|
Health Risk |
Pathogenic |
Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome, Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome |
| RS2524377897 |
CLCNKB
|
Health Risk |
Pathogenic |
— |
| RS2524386003 |
CLCNKB
|
Health Risk |
Likely pathogenic |
Bartter disease type 3, Bartter disease type 3 |
| RS2524387018 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2524389129 |
CLCNKB
|
Health Risk |
Likely pathogenic |
Bartter disease type 3, Bartter disease type 3 |
| RS2524389961 |
CLCNKB
|
Health Risk |
Likely pathogenic |
Bartter disease type 3, Bartter disease type 3 |
| RS2524392157 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS2524392830 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS2524395082 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524395125 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524395369 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524395491 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524395686 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524395776 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524396617 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524396708 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524398223 |
AMPD2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9 |
| RS2524398325 |
P3H1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524399538 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524399688 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524400773 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta |
| RS2524400774 |
CLCNKB
|
Health Risk |
Likely pathogenic |
— |
| RS2524401276 |
CLCNKB
|
Health Risk |
Likely pathogenic |
— |
| RS2524403418 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, Melanoma |
| RS2524403492 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524403534 |
COL4A5
|
Health Risk |
Pathogenic |
COL4A5-related disorder, COL4A5-related disorder |
| RS2524403583 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524403936 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524403948 |
COL4A5
|
Health Risk |
Pathogenic |
COL4A5-related disorder, COL4A5-related disorder |
| RS2524404029 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524404043 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524404117 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524404232 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, COL4A5-related disorder |
| RS2524405777 |
VPS13D
|
Health Risk |
Pathogenic |
Autosomal recessive cerebellar ataxia, Autosomal recessive cerebellar ataxia |
| RS2524405833 |
VPS13D
|
Health Risk |
Pathogenic |
— |
| RS2524407451 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524407657 |
COL4A5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, X-linked Alport syndrome |
| RS2524408042 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524408108 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524408358 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524408618 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524408721 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524414128 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524414237 |
COL4A5
|
Health Risk |
Likely pathogenic |
COL4A5-related disorder, COL4A5-related disorder |
| RS2524414327 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524414414 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524414428 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2524414626 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524414663 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524415501 |
AMPD2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63 |
| RS2524418358 |
P3H1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524419851 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524419875 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524419984 |
HUWE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked syndromic |
| RS2524420036 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524420389 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524420445 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524420680 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, Nonpapillary renal cell carcinoma |
| RS2524420706 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524422337 |
HUWE1
|
Health Risk |
Likely pathogenic |
HUWE1-related disorder, HUWE1-related disorder |
| RS2524422819 |
COL4A5
|
Health Risk |
Likely pathogenic |
COL4A5-related disorder, COL4A5-related disorder |
| RS2524422870 |
EPHA10
|
Health Risk |
Pathogenic |
Nonsyndromic Deafness, Hearing loss |
| RS2524422937 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524423431 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2524423658 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2524430122 |
SLC35A3
|
Health Risk |
Pathogenic |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |
| RS2524431684 |
SLC35A3
|
Health Risk |
Pathogenic |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |
| RS2524432375 |
SLC35A3
|
Health Risk |
Pathogenic |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |